|
Related Links |
|
AKIN (Acute Kidney Injury Network) is an international interdisciplinary group of adult and pediatric nephrologists and critical care physicians, and others interested in Acute Kidney Injury (AKI). |
|
MUSC Nephrology Proteomics Lab The proteomics lab in the Nephrology Division at the Medical University of South Carolina focuses on renal biomarker discovery and pathophysiology of renal diseases. The laboratory uses a variety of moderate to high throughput techniques. |
|
Acute Dialysis Quality Initiative (ADQI) The intent of ADQI is to provide an objective, dispassionate distillation of the literature and description of the current state of practice of dialysis and related therapies. The purpose is to develop a consensus of opinion, with evidence where possible, on best practice and to articulate a research agenda to focus on important unanswered questions. |
|
Acute Renal Failure Trial Network (ATN) The Acute Renal Failure Trial Network (ATN) Study is a clinical research study that is jointly sponsored by the Department of Veterans Affairs and the National Institutes of Health in order to determine if an increased dose of dialysis will decrease mortality rates in patients with acute renal failure (ARF). |
|
Clicking this link will query the Pubmed database for publications containing the terms “acute renal failure” or “acute kidney injury” or “acute kidney failure”. The publications are listed with the most recent ones first. |
|
Southern Acute Kidney Injury Network |
|
SAKInet |
|
Southeastern Kidney Disease Consortium The Southeastern kidney disease consortium is a group of specialist and generalist physicians that take care of patients with kidney disease. The group collects clinical data and fluid and tissue samples for analysis. |
|
To contact us: |
|
E-mail: sakinet@sakinet.org |
|
Home | Investigators | Projects | Links | Nephrology Proteomics | SEKDC ! Biomarkers CoEE |
|
Renal Disease Biomarkers Center of Excellence The center of excellence is a group of academic scientists interested in improving the lives of patients with kidney disease through discovery and use of biomarkers and testing and use of new therapies. It also is as the coordinating center for data and samples obtained through the SEKDC.. |